OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Effects of Physical Activity on Cancer Patients Undergoing Treatment with Immune Checkpoint Inhibitors: A Scoping Review
Amy L. Shaver, Swapnil Sharma, Nikita Nikita, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6364-6364
Open Access | Times Cited: 15
Amy L. Shaver, Swapnil Sharma, Nikita Nikita, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6364-6364
Open Access | Times Cited: 15
Showing 15 citing articles:
Exercise as cancer treatment: A clinical oncology framework for exercise oncology research
Kerry S. Courneya, Christopher M. Booth
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
Kerry S. Courneya, Christopher M. Booth
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
Human lymphocytes mobilized with exercise have an anti-tumor transcriptomic profile and exert enhanced graft-versus-leukemia effects in xenogeneic mice
Helena Batatinha, Douglass M. Diak, Grace M. Niemiro, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Helena Batatinha, Douglass M. Diak, Grace M. Niemiro, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Immune Checkpoint Inhibitors in Cancer Therapy—How Can We Improve Clinical Benefits?
Constantin N. Baxevanis
Cancers (2023) Vol. 15, Iss. 3, pp. 881-881
Open Access | Times Cited: 9
Constantin N. Baxevanis
Cancers (2023) Vol. 15, Iss. 3, pp. 881-881
Open Access | Times Cited: 9
An integrated framework for the study of exercise across the postdiagnosis cancer continuum
Kerry S. Courneya, Margaret L. McNeely, Christopher M. Booth, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Kerry S. Courneya, Margaret L. McNeely, Christopher M. Booth, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Role of Clock Genes and Circadian Rhythm in Renal Cell Carcinoma: Recent Evidence and Therapeutic Consequences
Matteo Santoni, Javier Molina‐Cerrillo, Giorgio Santoni, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 408-408
Open Access | Times Cited: 8
Matteo Santoni, Javier Molina‐Cerrillo, Giorgio Santoni, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 408-408
Open Access | Times Cited: 8
Immune Checkpoint Inhibitors and the Exposome: Host-Extrinsic Factors Determine Response, Survival, and Toxicity
Elio Gregory Pizzutilo, Rebecca Romanò, Laura Roazzi, et al.
Cancer Research (2023) Vol. 83, Iss. 14, pp. 2283-2296
Open Access | Times Cited: 7
Elio Gregory Pizzutilo, Rebecca Romanò, Laura Roazzi, et al.
Cancer Research (2023) Vol. 83, Iss. 14, pp. 2283-2296
Open Access | Times Cited: 7
Exercise to transform tumours from cold to hot and improve immunotherapy responsiveness
Brindley Hapuarachi, Sarah Danson, Jonathan Wadsley, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Brindley Hapuarachi, Sarah Danson, Jonathan Wadsley, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Can Exercise Enhance the Efficacy of Checkpoint Inhibition by Modulating Anti-Tumor Immunity?
Christina Brummer, Tobias Pukrop, Joachim Wiskemann, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4668-4668
Open Access | Times Cited: 5
Christina Brummer, Tobias Pukrop, Joachim Wiskemann, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4668-4668
Open Access | Times Cited: 5
Experiences of Patients with Breast Cancer Participating in a Prehabilitation Program: A Qualitative Study
Anabel Casanovas-Álvarez, Raquel Sebio, Jaume Masià, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 13, pp. 3732-3732
Open Access | Times Cited: 1
Anabel Casanovas-Álvarez, Raquel Sebio, Jaume Masià, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 13, pp. 3732-3732
Open Access | Times Cited: 1
Is There a Role for Exercise When Treating Patients with Cancer with Immune Checkpoint Inhibitors? A Scoping Review
Jasmine Handford, Miaoqi Chen, Ridesh Rai, et al.
Cancers (2022) Vol. 14, Iss. 20, pp. 5039-5039
Open Access | Times Cited: 5
Jasmine Handford, Miaoqi Chen, Ridesh Rai, et al.
Cancers (2022) Vol. 14, Iss. 20, pp. 5039-5039
Open Access | Times Cited: 5
Feasibility and Impact of Adapted Physical Activity (APA) in Cancer Outpatients Beginning Medical Anti-Tumoral Treatment: The UMA-CHAPA Study
Amélie Lemoine, Marine Perrier, Camille Mazza, et al.
Cancers (2022) Vol. 14, Iss. 8, pp. 1993-1993
Open Access | Times Cited: 3
Amélie Lemoine, Marine Perrier, Camille Mazza, et al.
Cancers (2022) Vol. 14, Iss. 8, pp. 1993-1993
Open Access | Times Cited: 3
Effect of the immune microenvironment on prognosis in oesophageal adenocarcinoma.
Dimitra Peristeri, Munir Tarazi, Patrick J. Casey, et al.
Best Practice & Research Clinical Gastroenterology (2024) Vol. 72, pp. 101954-101954
Closed Access
Dimitra Peristeri, Munir Tarazi, Patrick J. Casey, et al.
Best Practice & Research Clinical Gastroenterology (2024) Vol. 72, pp. 101954-101954
Closed Access
Side Effects of Cancer Immunotherapies: Dermatologic and Rheumatologic Toxicities
Daniele Frisone, Pierre O. Chappuis
Praxis (2023) Vol. 112, Iss. 3, pp. 184-188
Closed Access | Times Cited: 1
Daniele Frisone, Pierre O. Chappuis
Praxis (2023) Vol. 112, Iss. 3, pp. 184-188
Closed Access | Times Cited: 1
Data from Immune Checkpoint Inhibitors and the Exposome: Host-Extrinsic Factors Determine Response, Survival, and Toxicity
Elio Gregory Pizzutilo, Rebecca Romanò, Laura Roazzi, et al.
(2023)
Open Access
Elio Gregory Pizzutilo, Rebecca Romanò, Laura Roazzi, et al.
(2023)
Open Access
Data from Immune Checkpoint Inhibitors and the Exposome: Host-Extrinsic Factors Determine Response, Survival, and Toxicity
Elio Gregory Pizzutilo, Rebecca Romanò, Laura Roazzi, et al.
(2023)
Open Access
Elio Gregory Pizzutilo, Rebecca Romanò, Laura Roazzi, et al.
(2023)
Open Access
